The Tumor Suppressor Protein TEP1/PTEN/MMAC1 and Human Breast Cancer
Abstract
PTEN is an important tumor suppressor. Both inherited mutations and somatic mutations in the PTEN gene have been frequently found in a variety of human cancers, including the breast cancer, PTEN protein has been shown to possess phosphatase activity toward phosphatidylinositol (3,4,5)-trisphosphate (PIP3). We have demonstrated that PTEN tumor suppressor dephosphorylates PIP3 in vivo and negatively regulates the PI 3- kinase/Akt signaling pathway. We have further shown that PTEN modulates cell cycle progression and a critical target for PTEN-regulated pathway is the CDK inhibitor p27KIP1. p27KIP1 is itself known as an Important prognosis marker for human breast cancer, We hypothesize that loss of PTEN in human cancer cells lead to reduction of p27KIP1 levels, which in turn promote cell cycle progression and tumorigenesis. We have also demonstrated that PTEN controls cell motility, and such regulation is mediated through regulation of the activities of Racl and Cdc42. Racl and Cdc42 are two small GTPases that have been implicated in cell motility and tumor invasion processes. Our studies have provided a molecular explanation for the increased cell motility and thus invasion associated with loss of PTEN in human breast cancer cells.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 2002
- Accession Number
- ADA411250
Entities
People
- Hong Sun
Organizations
- Yale University